Paclitaxel-loaded poly (n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer

F Ren, R Chen, Y Wang, Y Sun, Y Jiang, G Li - Pharmaceutical research, 2011 - Springer
Purpose The aim of this study was to test the ability of paclitaxel-loaded poly
(butylcyanoacrylate)(PBCA) nanoparticles to overcome multidrug resistance (MDR) in …
被引用次数：66 相关文章

Paclitaxel-loaded poly (n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer

F Ren, R Chen, Y Wang, Y Sun… - Pharmaceutical …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose The aim of this study was to test the ability of paclitaxel-loaded poly
(butylcyanoacrylate)(PBCA) nanoparticles to overcome multidrug resistance (MDR) in …

[引用][C] Paclitaxel-Loaded Poly (n-butylcyanoacrylate) Nanoparticle Delivery System to Overcome Multidrug Resistance in Ovarian Cancer

F Ren, R Chen, Y Wang, Y Sun, Y Jiang… - Pharmaceutical …, 2010 - cir.nii.ac.jp
Paclitaxel-Loaded Poly(n-butylcyanoacrylate) Nanoparticle Delivery System to Overcome
Multidrug Resistance in Ovarian Cancer | CiNii Research CiNii 国立情報学研究所 学術情報 …

Paclitaxel-loaded poly (n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer

F Ren, R Chen, Y Wang, Y Sun, Y Jiang… - Pharmaceutical …, 2011 - hero.epa.gov
PURPOSE: The aim of this study was to test the ability of paclitaxel-loaded poly
(butylcyanoacrylate)(PBCA) nanoparticles to overcome multidrug resistance (MDR) in …

Paclitaxel-loaded poly (n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer.

F Ren, R Chen, Y Wang, Y Sun, Y Jiang… - Pharmaceutical …, 2010 - europepmc.org
Purpose The aim of this study was to test the ability of paclitaxel-loaded poly
(butylcyanoacrylate)(PBCA) nanoparticles to overcome multidrug resistance (MDR) in …

Paclitaxel-Loaded Poly (n-butylcyanoacrylate) Nanoparticle Delivery System to Overcome Multidrug Resistance in Ovarian Cancer.

F Ren, R Chen, Y Wang, Y Sun… - Pharmaceutical …, 2011 - search.ebscohost.com
Purpose: The aim of this study was to test the ability of paclitaxel-loaded poly
(butylcyanoacrylate)(PBCA) nanoparticles to overcome multidrug resistance (MDR) in …

Paclitaxel-Loaded Poly (n-butylcyanoacrylate) Nanoparticle Delivery System to Overcome Multidrug Resistance in Ovarian Cancer

F Ren, R Chen, Y Wang, Y Sun, Y Jiang, G Li - Pharmaceutical Research, 2011 - infona.pl
Purpose The aim of this study was to test the ability of paclitaxel-loaded poly
(butylcyanoacrylate)(PBCA) nanoparticles to overcome multidrug resistance (MDR) in …

Paclitaxel-Loaded Poly (n-butylcyanoacrylate) Nanoparticle Delivery System to Overcome Multidrug Resistance in Ovarian Cancer

F Ren, R Chen, Y Wang, Y Sun… - Pharmaceutical …, 2011 - search.proquest.com
Paclitaxel-Loaded Poly(n-butylcyanoacrylate) Nanoparticle Delivery System to Overcome
Multidrug Resistance in Ovarian Cancer Page 1 RESEARCH PAPER Paclitaxel-Loaded …

[引用][C] Paclitaxel-Loaded Poly (n-butylcyanoacrylate) Nanoparticle Delivery System to Overcome Multidrug Resistance in Ovarian Cancer

FEI REN, R CHEN, Y WANG, Y SUN… - Pharmaceutical …, 2011 - pascal-francis.inist.fr
Paclitaxel-Loaded Poly(n-butylcyanoacrylate) Nanoparticle Delivery System to Overcome
Multidrug Resistance in Ovarian Cancer CNRS Inist Pascal-Francis CNRS Pascal and …

[引用][C] Paclitaxel-Loaded Poly (n-butylcyanoacrylate) Nanoparticle Delivery System to Overcome Multidrug Resistance in Ovarian Cancer

F Ren, R Chen, Y Wang, Y Sun, Y Jiang, G Li - Pharmaceutical Research, 2011 - Springer